Free Trial

Precigen (PGEN) Competitors

Precigen logo
$3.91 -0.17 (-4.17%)
Closing price 10/22/2025 04:00 PM Eastern
Extended Trading
$3.95 +0.04 (+1.02%)
As of 10/22/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PGEN vs. MENS, KYMR, AKRO, NAMS, CRNX, GMTX, LNTH, VKTX, PRAX, and MIRM

Should you be buying Precigen stock or one of its competitors? The main competitors of Precigen include Jyong Biotech (MENS), Kymera Therapeutics (KYMR), Akero Therapeutics (AKRO), NewAmsterdam Pharma (NAMS), Crinetics Pharmaceuticals (CRNX), Gemini Therapeutics (GMTX), Lantheus (LNTH), Viking Therapeutics (VKTX), Praxis Precision Medicines (PRAX), and Mirum Pharmaceuticals (MIRM). These companies are all part of the "pharmaceutical products" industry.

Precigen vs. Its Competitors

Jyong Biotech (NASDAQ:MENS) and Precigen (NASDAQ:PGEN) are both pharmaceutical products companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, analyst recommendations, institutional ownership and risk.

33.5% of Precigen shares are held by institutional investors. 47.1% of Precigen shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Precigen has a consensus target price of $8.25, suggesting a potential upside of 111.00%. Given Precigen's stronger consensus rating and higher possible upside, analysts clearly believe Precigen is more favorable than Jyong Biotech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jyong Biotech
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Precigen
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, Precigen had 3 more articles in the media than Jyong Biotech. MarketBeat recorded 4 mentions for Precigen and 1 mentions for Jyong Biotech. Precigen's average media sentiment score of 0.45 beat Jyong Biotech's score of 0.00 indicating that Precigen is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Jyong Biotech
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Precigen
0 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Jyong Biotech has higher earnings, but lower revenue than Precigen.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jyong BiotechN/AN/AN/AN/AN/A
Precigen$3.92M297.21-$126.24M-$0.42-9.31

Jyong Biotech has a net margin of 0.00% compared to Precigen's net margin of -2,868.66%. Jyong Biotech's return on equity of 0.00% beat Precigen's return on equity.

Company Net Margins Return on Equity Return on Assets
Jyong BiotechN/A N/A N/A
Precigen -2,868.66%-842.83%-78.98%

Summary

Precigen beats Jyong Biotech on 8 of the 11 factors compared between the two stocks.

Get Precigen News Delivered to You Automatically

Sign up to receive the latest news and ratings for PGEN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PGEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PGEN vs. The Competition

MetricPrecigenMED IndustryMedical SectorNASDAQ Exchange
Market Cap$1.22B$3.47B$6.16B$10.67B
Dividend YieldN/A2.24%5.72%4.86%
P/E Ratio-9.3122.9129.1027.13
Price / Sales297.21463.56584.37126.20
Price / CashN/A45.5937.1261.42
Price / Book30.0810.2912.186.43
Net Income-$126.24M-$52.53M$3.33B$276.63M
7 Day Performance12.03%-0.60%-0.74%-0.77%
1 Month Performance5.39%10.30%5.32%0.68%
1 Year Performance315.91%13.51%68.16%32.03%

Precigen Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PGEN
Precigen
4.3396 of 5 stars
$3.91
-4.2%
$8.25
+111.0%
+317.2%$1.22B$3.92M-9.31190
MENS
Jyong Biotech
N/A$59.01
+0.0%
N/AN/A$4.49BN/A0.0031Positive News
KYMR
Kymera Therapeutics
1.7603 of 5 stars
$60.50
+1.1%
$62.74
+3.7%
+15.4%$4.33B$47.07M-17.44170News Coverage
Upcoming Earnings
Analyst Forecast
AKRO
Akero Therapeutics
3.8422 of 5 stars
$53.91
+0.1%
$73.38
+36.1%
+81.2%$4.31BN/A-26.9630Positive News
NAMS
NewAmsterdam Pharma
3.601 of 5 stars
$37.66
+3.5%
$43.20
+14.7%
+85.0%$4.24B$45.56M-23.254Trending News
Analyst Forecast
Analyst Revision
CRNX
Crinetics Pharmaceuticals
4.3355 of 5 stars
$42.45
+2.1%
$74.45
+75.4%
-32.2%$4.00B$1.04M-10.33210Positive News
GMTX
Gemini Therapeutics
N/A$89.94
+21.0%
N/A+69.2%$3.90BN/A-89.9430High Trading Volume
LNTH
Lantheus
4.5902 of 5 stars
$56.60
+1.8%
$74.50
+31.6%
-49.3%$3.85B$1.53B15.05700
VKTX
Viking Therapeutics
3.7799 of 5 stars
$33.75
+0.7%
$86.42
+156.0%
-49.3%$3.79BN/A-22.0620Earnings Report
PRAX
Praxis Precision Medicines
2.178 of 5 stars
$175.07
-7.9%
$222.36
+27.0%
+155.3%$3.71B$8.55M-14.24110Trending News
Analyst Forecast
Analyst Revision
High Trading Volume
MIRM
Mirum Pharmaceuticals
3.8706 of 5 stars
$73.03
-0.7%
$79.70
+9.1%
+75.4%$3.67B$336.89M-60.35140

Related Companies and Tools


This page (NASDAQ:PGEN) was last updated on 10/23/2025 by MarketBeat.com Staff
From Our Partners